HUE047263T2 - Staphylococcus aureus antigének stabil immunogén készítményei - Google Patents
Staphylococcus aureus antigének stabil immunogén készítményeiInfo
- Publication number
- HUE047263T2 HUE047263T2 HUE16193095A HUE16193095A HUE047263T2 HU E047263 T2 HUE047263 T2 HU E047263T2 HU E16193095 A HUE16193095 A HU E16193095A HU E16193095 A HUE16193095 A HU E16193095A HU E047263 T2 HUE047263 T2 HU E047263T2
- Authority
- HU
- Hungary
- Prior art keywords
- staphylococcus aureus
- immunogenic compositions
- aureus antigens
- stable immunogenic
- stable
- Prior art date
Links
- 241000191967 Staphylococcus aureus Species 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 230000002163 immunogen Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201061426476P | 2010-12-22 | 2010-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE047263T2 true HUE047263T2 (hu) | 2020-04-28 |
Family
ID=45444677
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE16193095A HUE047263T2 (hu) | 2010-12-22 | 2011-12-21 | Staphylococcus aureus antigének stabil immunogén készítményei |
| HUE11804822A HUE033072T2 (hu) | 2010-12-22 | 2011-12-21 | Staphylococcus aureus antigének immunogén készítményei |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE11804822A HUE033072T2 (hu) | 2010-12-22 | 2011-12-21 | Staphylococcus aureus antigének immunogén készítményei |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20130259896A1 (enExample) |
| EP (2) | EP2654784B1 (enExample) |
| JP (1) | JP6097478B2 (enExample) |
| KR (2) | KR101808398B1 (enExample) |
| CN (1) | CN103826656B (enExample) |
| AU (1) | AU2011346535B2 (enExample) |
| BR (1) | BR112013016153A2 (enExample) |
| CA (1) | CA2819120C (enExample) |
| DK (2) | DK3150222T3 (enExample) |
| ES (2) | ES2769425T3 (enExample) |
| HU (2) | HUE047263T2 (enExample) |
| IL (1) | IL226793B (enExample) |
| MX (1) | MX350170B (enExample) |
| PL (2) | PL3150222T3 (enExample) |
| PT (2) | PT2654784T (enExample) |
| RU (1) | RU2570730C2 (enExample) |
| SI (2) | SI2654784T1 (enExample) |
| WO (1) | WO2012085872A2 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2730275T3 (es) | 2004-09-22 | 2019-11-11 | Glaxosmithkline Biologicals Sa | Composición inmunógena para uso en vacunación contra estafilococos |
| SI2445522T1 (sl) | 2009-06-22 | 2017-10-30 | Wyeth Llc | Imunogeni sestavki antigenov Staphylococcusa aureusa |
| EP3461496B1 (en) | 2009-06-22 | 2023-08-23 | Wyeth LLC | Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions |
| ES2614807T3 (es) * | 2010-06-04 | 2017-06-02 | Wyeth Llc | Formulaciones vacunales |
| AU2012266880A1 (en) * | 2011-03-16 | 2013-10-03 | Regents Of The University Of Minnesota | Compositions and methods for inducing immune responses against bacteria in the genus staphylococcus |
| GB201310008D0 (en) * | 2013-06-05 | 2013-07-17 | Glaxosmithkline Biolog Sa | Immunogenic composition for use in therapy |
| WO2015082571A1 (en) * | 2013-12-04 | 2015-06-11 | Glycovaxyn Ag | Prevention of staphylococcus aureus infections by glycoprotein vaccines synthesized in escherichia coli |
| IL310015B1 (en) * | 2013-12-31 | 2025-10-01 | Access To Advanced Health Inst | Single vial formulation |
| DK3129001T3 (da) * | 2014-04-10 | 2020-01-20 | Asit Biotech S A | Hsp-fri fremstilling af allergen |
| US20200360500A1 (en) * | 2017-08-16 | 2020-11-19 | Merck Sharp & Dohme Corp. | Pneumococcal conjugate vaccine formulations |
| GB201802339D0 (en) | 2018-02-13 | 2018-03-28 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
| KR102646145B1 (ko) | 2018-05-31 | 2024-03-11 | 주식회사 엑소코바이오 | 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 모공 축소용 조성물 |
| KR102058961B1 (ko) | 2018-07-28 | 2019-12-24 | 주식회사 엑소코바이오 | 엑소좀의 동결건조 방법 |
| KR102163806B1 (ko) | 2018-07-30 | 2020-10-07 | 주식회사 엑소코바이오 | 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 피지분비 감소용 조성물 |
| BR112022013730A2 (pt) * | 2020-01-13 | 2022-10-11 | Aptevo Res & Development Llc | Métodos e composições para prevenir a adsorção de proteínas terapêuticas aos componentes do sistema de distribuição de drogas |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4902506A (en) | 1983-07-05 | 1990-02-20 | The University Of Rochester | Immunogenic conjugates |
| US4673574A (en) | 1981-08-31 | 1987-06-16 | Anderson Porter W | Immunogenic conjugates |
| US4708871A (en) | 1983-03-08 | 1987-11-24 | Commonwealth Serum Laboratories Commission | Antigenically active amino acid sequences |
| SE8405493D0 (sv) | 1984-11-01 | 1984-11-01 | Bror Morein | Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel |
| US5078996A (en) | 1985-08-16 | 1992-01-07 | Immunex Corporation | Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| HU212924B (en) | 1989-05-25 | 1996-12-30 | Chiron Corp | Adjuvant formulation comprising a submicron oil droplet emulsion |
| IT1253009B (it) | 1991-12-31 | 1995-07-10 | Sclavo Ricerca S R L | Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini |
| US5571515A (en) | 1994-04-18 | 1996-11-05 | The Wistar Institute Of Anatomy & Biology | Compositions and methods for use of IL-12 as an adjuvant |
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6008341A (en) | 1994-08-22 | 1999-12-28 | The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin | S. aureus fibrinogen binding protein gene |
| BE1008978A5 (fr) | 1994-12-27 | 1996-10-01 | Solvay | Adjuvants pour vaccins. |
| JPH11514870A (ja) | 1995-10-16 | 1999-12-21 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 新規な唾液結合タンパク質 |
| GB9622159D0 (en) | 1996-10-24 | 1996-12-18 | Solvay Sociutu Anonyme | Polyanionic polymers as adjuvants for mucosal immunization |
| GB9622660D0 (en) | 1996-10-31 | 1997-01-08 | Biocine Spa | Immunogenic detoxified mutant toxin |
| US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| AU1537699A (en) | 1997-11-26 | 1999-06-15 | Bioresearch Ireland a division of Eolas - The Irish Science and Technology Agency | Extracellular matrix-binding proteins from (staphylococcus aureus) |
| US6680195B1 (en) | 1997-11-26 | 2004-01-20 | Inhibitex, Inc. | Extracellular matrix-binding proteins from staphylococcus aureus |
| WO2000012131A1 (en) * | 1998-08-31 | 2000-03-09 | Inhibitex, Inc. | Multicomponent vaccines |
| US6936258B1 (en) | 1999-03-19 | 2005-08-30 | Nabi Biopharmaceuticals | Staphylococcus antigen and vaccine |
| US7115730B1 (en) | 1999-04-27 | 2006-10-03 | Chiron Srl | Immunogenic detoxified mutant E. coli LT-A-toxin |
| US7384640B1 (en) | 1999-09-30 | 2008-06-10 | Wyeth Holdings Corporation | Mutant cholera holotoxin as an adjuvant |
| RU2413520C2 (ru) | 2000-06-08 | 2011-03-10 | Интерселл Аг | Вакцинная композиция, содержащая иммуностимулирующие олигодезоксинуклеотиды |
| AT410635B (de) | 2000-10-18 | 2003-06-25 | Cistem Biotechnologies Gmbh | Vakzin-zusammensetzung |
| CN1541111A (zh) | 2001-06-07 | 2004-10-27 | ���Ͽع�����˾ | 作为佐剂的霍乱全毒素的突变形式 |
| US7285281B2 (en) | 2001-06-07 | 2007-10-23 | Wyeth Holdings Corporation | Mutant forms of cholera holotoxin as an adjuvant |
| EP2320233A1 (en) | 2001-06-15 | 2011-05-11 | Inhibitex, Inc. | Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| GB0118249D0 (en) * | 2001-07-26 | 2001-09-19 | Chiron Spa | Histidine vaccines |
| CA2517439C (en) | 2003-03-07 | 2013-07-23 | Wyeth Holdings Corporation | Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections |
| EP1603950A2 (en) | 2003-03-17 | 2005-12-14 | Wyeth Holdings Corporation | Mutant cholera holotoxin as an adjuvant and an antigen carrier protein |
| GB0323103D0 (en) | 2003-10-02 | 2003-11-05 | Chiron Srl | De-acetylated saccharides |
| ES2730275T3 (es) * | 2004-09-22 | 2019-11-11 | Glaxosmithkline Biologicals Sa | Composición inmunógena para uso en vacunación contra estafilococos |
| KR101541383B1 (ko) * | 2006-03-30 | 2015-08-03 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 면역원성 조성물 |
| GB0606416D0 (en) * | 2006-03-30 | 2006-05-10 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| AR060188A1 (es) * | 2006-03-30 | 2008-05-28 | Glaxosmithkline Biolog Sa | Procedimiento de conjugacion |
| WO2007127668A2 (en) | 2006-04-26 | 2007-11-08 | Wyeth | Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations |
| CL2007003209A1 (es) * | 2006-11-07 | 2008-05-09 | Acambis Inc | Composicion que comprende una vacuna de flavivirus vivos atenuados; composicion que comprende un producto farmaceutico derivado de virus o proteina; un metodo para la elaboracion de una composicion terapeutica que comprende liofilizar las composicion |
| MX2010008799A (es) | 2008-03-05 | 2010-09-07 | Sanofi Pasteur | Proceso para estabilizar una composicion de vacuna que contiene adyuvante. |
| SI2445522T1 (sl) * | 2009-06-22 | 2017-10-30 | Wyeth Llc | Imunogeni sestavki antigenov Staphylococcusa aureusa |
-
2011
- 2011-12-21 PT PT118048222T patent/PT2654784T/pt unknown
- 2011-12-21 ES ES16193095T patent/ES2769425T3/es active Active
- 2011-12-21 PL PL16193095T patent/PL3150222T3/pl unknown
- 2011-12-21 PT PT161930953T patent/PT3150222T/pt unknown
- 2011-12-21 DK DK16193095.3T patent/DK3150222T3/da active
- 2011-12-21 PL PL11804822T patent/PL2654784T3/pl unknown
- 2011-12-21 HU HUE16193095A patent/HUE047263T2/hu unknown
- 2011-12-21 US US13/993,887 patent/US20130259896A1/en not_active Abandoned
- 2011-12-21 EP EP11804822.2A patent/EP2654784B1/en active Active
- 2011-12-21 EP EP16193095.3A patent/EP3150222B1/en active Active
- 2011-12-21 RU RU2013128277/15A patent/RU2570730C2/ru active IP Right Revival
- 2011-12-21 DK DK11804822.2T patent/DK2654784T3/en active
- 2011-12-21 KR KR1020157031951A patent/KR101808398B1/ko not_active Expired - Fee Related
- 2011-12-21 CN CN201180068105.5A patent/CN103826656B/zh not_active Expired - Fee Related
- 2011-12-21 AU AU2011346535A patent/AU2011346535B2/en not_active Ceased
- 2011-12-21 SI SI201131064A patent/SI2654784T1/sl unknown
- 2011-12-21 SI SI201131825T patent/SI3150222T1/sl unknown
- 2011-12-21 HU HUE11804822A patent/HUE033072T2/hu unknown
- 2011-12-21 KR KR1020137018851A patent/KR20130114210A/ko not_active Ceased
- 2011-12-21 ES ES11804822.2T patent/ES2614815T3/es active Active
- 2011-12-21 BR BR112013016153A patent/BR112013016153A2/pt not_active Application Discontinuation
- 2011-12-21 WO PCT/IB2011/055883 patent/WO2012085872A2/en not_active Ceased
- 2011-12-21 MX MX2013006960A patent/MX350170B/es active IP Right Grant
- 2011-12-21 CA CA2819120A patent/CA2819120C/en active Active
- 2011-12-22 JP JP2011280781A patent/JP6097478B2/ja not_active Expired - Fee Related
-
2013
- 2013-06-06 IL IL226793A patent/IL226793B/en active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL217084A0 (en) | Immunogenic compositions of staphylococcus aureus antigens | |
| IL226793B (en) | Stable immunogenic compositions of staphylococcus aureus antigens | |
| ZA202002470B (en) | Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof | |
| IL231104A0 (en) | Helper assemblies of antigens for Staphylococcus aureus | |
| EP2549993A4 (en) | ANTIMICROBIAL COMPOSITIONS | |
| ZA201403788B (en) | Stable pesticidal compositions | |
| ZA201300073B (en) | Compositions comprising optical benefit agents | |
| AP2013006786A0 (en) | Pesticidal compositions | |
| AP2013006769A0 (en) | Pesticidal compositions | |
| BR112013017664A2 (pt) | composições de pó de cacau | |
| GB201015132D0 (en) | Vaccine composition | |
| IL238328A0 (en) | Stable preparations that include peracetic acid | |
| PL2768936T3 (pl) | Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie | |
| EP2531026A4 (en) | ANTIMICROBIAL FORMULATIONS ON POLYSACCHARID BASE | |
| EP2605654A4 (en) | ANTIMICROBIAL COMPOSITIONS | |
| PL2407155T3 (pl) | Formulacje inekalcytolu | |
| ZA201301908B (en) | Immunogenic compositions | |
| GB201013150D0 (en) | Antimicrobial compositions | |
| GB201111128D0 (en) | Antimicrobial compositions | |
| GB201010944D0 (en) | Antimicrobial compositions | |
| GB201003799D0 (en) | Antimicrobial compositions | |
| GB201002594D0 (en) | Antimicrobial compositions | |
| AU2012900227A0 (en) | Compositions of nimorazole | |
| GB201005587D0 (en) | Novel formulations |